Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001178913-14-001347)

Filing Details

Accession Number:: 0001178913-14-001347
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-04-18 11:36:19
Reporting Period:: 2014-04-14

Filing Date:: 2014-04-18
Accepted Time:: 2014-04-18 11:36:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1176309	Oramed Pharmaceuticals Inc.	ORMP	Pharmaceutical Preparations (2834)	980376008

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1443692	Harold Jacob	Haadmur Mebuyon 26, Harnot Jerusalem L3 95403		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-04-14	700	$14.41	700	No	4	P	Indirect	By wholly-owned corporation

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By wholly-owned corporation

Footnotes

In accordance with Section 16(b) of the Securities Exchange Act, the reporting person has submitted payment to the issuer to disgorge profits ($413) that he realized from this purchase and his sale of common stock that occurred on December 30, 2013 and that was reported on his Form 4 dated the same day.